CAPTRUST Financial Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7	Closed	–	–	4451
2022 Q2	$0	Buy	+7	New	–	﹤0.01%	5238